BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4917354)

  • 1. Maintenance therapy of chronic psychostic patients with a weekly oral dose of R 16 341. A controlled double-blind study.
    Baro F; Brugmans J; Dom R; Van Lommel R
    J Clin Pharmacol J New Drugs; 1970; 10(5):330-41. PubMed ID: 4917354
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent.
    Ota KY; Kurland AA; Slotnick VB
    J Clin Pharmacol; 1974 Apr; 14(4):202-9. PubMed ID: 4595986
    [No Abstract]   [Full Text] [Related]  

  • 3. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 4. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 5. [The depot neuroleptic agent fluspirilene (author's transl)].
    Angst J; Frei M; Scharfetter Chr
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):13-28. PubMed ID: 4602371
    [No Abstract]   [Full Text] [Related]  

  • 6. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluspirilene, a long-acting injectable neuroleptic.
    Ciccarelli G; Nosé F; Zuanazzi GF
    Acta Psychiatr Belg; 1972 Nov; 72(6):736-47. PubMed ID: 4679675
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A; Vereecken JL
    Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
    [No Abstract]   [Full Text] [Related]  

  • 9. A clinical study with propericiazine in chronic psychotic patients.
    Deutsch M; Ananth JV; Ban TA
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):353-8. PubMed ID: 4397391
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluspirilene, an injectable, and penfluridol, an oral long-acting, neuroleptic. A comparative double-blind trial in residual schizophrenia.
    Tanghe A; Vereecken JL
    Acta Psychiatr Scand; 1972; 48(4):315-31. PubMed ID: 4566564
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.
    Vandecasteele AJ; Vereecken JL
    Acta Psychiatr Scand; 1974; 50(3):346-53. PubMed ID: 4609288
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled trial of penfluridol in acute psychosis.
    van Praag HM; Schut T; Dols L; van Schilfgaarden R
    Br Med J; 1971 Dec; 4(5789):710-3. PubMed ID: 4943034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A long-acting neuroleptic. 3. Pilot study of penfluridol (R 16341)].
    Bobon J; Melon J; Mormont C; Dufrasne M; Pinchard A
    Acta Psychiatr Belg; 1970; 70(4):523-51. PubMed ID: 4923798
    [No Abstract]   [Full Text] [Related]  

  • 14. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience with a new neuroleptic (R. 6238)].
    Bonhour A; Borel RO
    Prensa Med Argent; 1971 Aug; 58(24):1265-6. PubMed ID: 4940120
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
    Gálfi B; Benson K; Grynaeus T
    Int Pharmacopsychiatry; 1973; 8(1):37-59. PubMed ID: 4595192
    [No Abstract]   [Full Text] [Related]  

  • 17. Penfluridol: an efficacious long-acting oral antipsychotic compound.
    Gallant DM; Mielke DH; Spirtes MA; Swanson WC; Bost R
    Am J Psychiatry; 1974 Jun; 131(6):699-702. PubMed ID: 4597305
    [No Abstract]   [Full Text] [Related]  

  • 18. A pilot study of pimozide in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):706-13. PubMed ID: 5000718
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of an oral long-acting anti-psychotic agent, penfluridol, in schizophrenia.
    White AC; Sims AC
    Curr Med Res Opin; 1974; 2(1):23-6. PubMed ID: 4841811
    [No Abstract]   [Full Text] [Related]  

  • 20. Liquid butaperazine in the treatment of chronic psychosis in a mental health clinic.
    Clare G; Simeon J; Fink M
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):57-63. PubMed ID: 4388407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.